Safe injection does not harm the recipient and does not expose DHCP to avoidable risks.
SEATTLE, WASHINGTON, USA, November 18, 2021 /EINPresswire.com/ – Market Snapshot:
Safe injection does not harm the recipient and does not expose DHCP to avoidable risks. Due to reports of infectious disease transmission due to mishandling of injectable drugs, the United States Centers for Disease Control and Prevention (CDC) now considers safe injection practices a formal part of standard precautions. Parenteral drugs must be accessible aseptically. This involves the use of a new sterile syringe / needle to prepare the drugs while preventing contact between the injected material and the non-sterile environment. Aseptic technique is a collection of medical practices and procedures that help protect patients from dangerous germs. Viruses, bacteria, and microbes are everywhere, so using aseptic technique helps prevent contamination of important equipment. By ensuring safe injection practices, hospitals can reduce the risk of needle stick injuries to patients, workers, and others, while reducing the risk of patients acquiring infection.
Get Sample Report With Latest Information @ https://www.coherentmarketinsights.com/insight/request-sample/1852
The major players operating in the global disposable asepsis safe injection needles market are Pall Corporation, Vita Needle Company, CR Bard, Inc., Retractable Technologies, Inc., Thomas Scientific, Inc., Terumo Corporation, Becton, Dickinson and Company, among others.
Main market drivers:
Frequent hospitalizations due to diseases associated with aging such as diabetes, cardiovascular disease, stroke, and falls are expected to drive the growth of the Asepsis Safe Injection Needles market over the period of forecast. The prevalence of diabetes, stroke and heart disease increases with age, especially in adults 65 years of age and older. For example, according to the United Nations (UN), there were 703 million people aged 65 or over globally in 2019, and that number is expected to double to 1.5 billion by 2050.
Additionally, the growing awareness of safe injection practices by healthcare organizations to reduce the potential risk of infection from blood-borne viruses is expected to drive the growth of the Safe Injection Needles for Asepsis market. disposable. Unsafe injection practices lead to the transmission of blood-borne pathogens. The three most common blood-borne pathogens (BBP) are human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus. For example, according to hiv.gov, in 2019, an estimated 34,800 new HIV infections occurred in the United States, and approximately 36,801 people were diagnosed with HIV in the United States.
Purchase this premium report to access all information @ https://www.coherentmarketinsights.com/insight/buy-now/1852
COVID-19 impact analysis:
Aseptic technique should be used in preparing the vaccines for administration to prevent the vaccines from being contaminated by microorganisms in the environment or by the people who prepare them. In addition, aseptic techniques are used to prevent the transfer of microorganisms from personnel and equipment during the manufacturing stages of aseptic preparations, but also during the administration of drugs, medical procedures and others. care process. Therefore, aseptic technique (the way of handling, preparing and storing drugs and vaccination supplies) is widely used to prepare vaccines and prevent infection. Safe and effective vaccines are essential to end the COVID-19 pandemic. The World Health Organization (WHO) works with partners to develop, manufacture and deploy safe and effective vaccines. This in turn should increase the growth of the market.
Key points to remember:
The Asepsis Safe Injection Needles Market is expected to exhibit a CAGR of XX% during the forecast period owing to increasing demand for blood donation or increasing number of blood donation campaigns worldwide. For example, according to the WHO, an increase of 7.8 million donated blood from voluntary unpaid donors was reported from 2013 to 2018. In total, 79 countries collect more than 90% of their blood supply from donors. unpaid voluntary blood; however, 56 countries collect more than 50% of their blood supply from family / replacement or paid donors.
Among the regions, North America and Asia-Pacific are expected to experience robust growth in the Asepsis Safe Injection Needles market owing to the increasing prevalence of chronic diseases, increasing demand for safe injections and strict rules and regulations for safe injection practices. Chronic diseases require blood tests, which in turn increases the demand for disposable aseptic safe injection needles. For example, according to the CDC, six in ten Americans live with at least one chronic illness. Chronic diseases such as heart disease, cancer and diabetes are the leading causes of death and disability in the United States
Request a PDF brochure with the latest information @ https://www.coherentmarketinsights.com/insight/request-pdf/1852
Chapter 1 Industry Overview
1.3 Scope of the research
1.4 Market Analysis by Regions
1.5 Global Disposable Asepsis Safe Injection Needles Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Impact on Disposable Asepsis Safe Injection Needles Industry
Chapter 2 Global Disposable Asepsis Safe Injection Needle Competition by Types, Applications and Major Regions and Countries
2.1 Global Disposable Asepsis Safe Injection Needle (Volume & Value) by Type
2.3 Global Disposable Asepsis Safe Injection Needle (Volume & Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional production market analysis
Chapter 4 Global Disposable Safe Injection Needles Sales, Consumption, Export Import by Regions (2016-2021)
Chapter 5 North America Safe Disposable Injection Needles Market Analysis
Chapter 6 East Asia Disposable Asepsis Safe Injection Needles Market Analysis
Chapter 7 Europe Disposable Asepsis Safe Injection Needles Market Analysis
Chapter 8 Southeast Asia Aseptic Safe Injection Needles Market Analysis
Chapter 9 Southeast Asia Safe Asepsis Injection Needles Market Analysis
Chapter 10 Middle East Disposable Asepsis Safe Injection Needle Market Analysis
Chapter 11 Africa Asepsis Safe Injection Needles Market Analysis
Chapter 12 Oceania Disposable Asepsis Safe Injection Needles Market Analysis
Chapter 13 South America Aseptic Safe Injection Needles Market Analysis
Chapter 14 Company Profiles and Key Figures of Disposable Asepsis Safe Injection Needles Industry
Chapter 15 Global Disposable Asepsis Safe Injection Needle Market Forecast (2021-2027)
Chapter 16 Conclusions
Consistent market information
1001 4th Ave, # 3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: + 1-206-701-6702
United Kingdom: + 44-020-8133-4027
Japan: + 050-5539-1737
India: + 91-848-285-0837